The University of Geneva has opened a tenure-track position for an assistant professor of human vaccine immunology… endowed by a Charity prior to a permanent University position as [...]
In the effort to eradicate tuberculosis as one of the world’s most deadly diseases, novel TB vaccines will be an important part of the solution. There is a pipeline of new TB vaccines that [...]
Prof. Kaufmann, chair of the scientific board of TBVAC2020 and member of the TBVI board, was honored with the Gagna A. & Ch. Van Heck Prize in recognition of his and his team’s work on [...]
On a regular basis EC highlights a project funded by the EC that has proven to be successful. TBVAC2020 is one of these success stories. TBVAC2020 aims to end tuberculosis by identifying [...]
On 6-7 June the kick off meeting of MTBVAC in Newborns took place in Cape Town, South Africa. This project contains a Phase 2a dose-defining safety and immunogenicity study is being carried out. [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
